Pacira | PCRX - L'Utile Operativo





L'Utile Operativo Cambiamento Data
Assertio Holdings USD -3.05M 569K 2024-09
Astellas Pharma JPY 48.57B 85.97B 2026-03
Bristol-Myers Squibb USD 4.2B 562M 2025-12
Cara Therapeutics USD -5.94M 3.55M 2025-09
Coherus Biosciences USD -39.08M 3.65M 2025-12
Heron Therapeutics USD 38K 3.83M 2025-12
Ironwood Pharmaceuticals USD 33.22M 7.58M 2024-12
J&J USD 6.62B 1.03B 2026-03
Ligand Pharmaceuticals USD 60.33M 40.29M 2026-03
Nektar Therapeutics USD -19.09M 15.26M 2025-12
Novo Nordisk DKK 59.62B 27.24B 2026-03
Omeros USD -35.41M 23.75M 2024-09
Pacira USD 4.62M 1.43M 2026-03
Perrigo USD 33.6M 50.8M 2026-03
Pfizer USD 4.99B 340M 2026-03
Supernus Pharmaceuticals USD -35.25M 49.07M 2026-03
Teva Pharmaceutical Industries USD 758M 271M 2026-03
Xeris Pharmaceuticals USD 16.77M 10.04M 2025-12
Xoma USD -15.64M 5.56M 2024-09
Zoetis USD 865M 30M 2026-03